Vortex fluidic regulated phospholipid equilibria involving liposomes down to sub-micelle size assemblies-Reference-Cited by-同舟云学术

Vortex fluidic regulated phospholipid equilibria involving liposomes down to sub-micelle size assemblies

Published:2024 Issue:4 Volume:6 Page:1202-1212
ISSN:2516-0230
Container-title:Nanoscale Advances
language:en
Short-container-title:Nanoscale Adv.

Author:

Joseph Nikita¹,Mirzamani Marzieh²,Abudiyah Tarfah¹,Al-Antaki Ahmed Hussein Mohammed¹³^ORCID,Jellicoe Matt¹,Harvey David P.¹,Crawley Emily¹,Chuah Clarence¹,Whitten Andrew E.⁴^ORCID,Gilbert Elliot Paul⁴^ORCID,Qian Shuo⁵^ORCID,He Lilin⁶^ORCID,Michael Michael Z.⁷,Kumari Harshita²^ORCID,Raston Colin L.¹^ORCID

Affiliation:

1. Flinders Institute for Nanoscale Science and Technology, College of Science and Engineering, Flinders University, Bedford Park, SA 5042, Australia

2. James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH 45267-0004, USA

3. Department of Chemistry, Faculty of Science, University of Kufa, Najaf 54001, Iraq

4. Australian Nuclear Science and Technology Organisation (ANSTO), Lucas Heights, NSW 2234, Australia

5. The Second Target Station Project of SNS, Oak Ridge National Laboratory, Oak Ridge, TN 37830, USA

6. Neutron Scattering Division, Oak Ridge National Laboratory, Oak Ridge, TN 37830, USA

7. Flinders Centre for Innovation in Cancer (FCIC), Flinders Medical Centre (FMC), Bedford Park, SA 5042, Australia

Abstract

Liposomes are formed in high yield under continuous flow in the vortex fluidic device with in situ SANS establishing the co-existence of ∼110 nm liposomes, rafts, micelles, or sub-micelle size assemblies for increasing rotational speed.

Funder

Australian Research Council

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/NA/D3NA01080E

Reference38 articles.

1. Liposomal drug delivery systems: From concept to clinical applications

2. Amphiphilic designer nano-carriers for controlled release: from drug delivery to diagnostics

3. Engineering exosomes as refined biological nanoplatforms for drug delivery

4. Engineering hybrid exosomes by membrane fusion with liposomes

5. Liposome production by microfluidics: potential and limiting factors